Brain rot, refers to the deterioration of one’s mental or intellectual state as a result of over-consuming "trivial or ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the efficacy results hoped for in a midstage study. The investigational ...

Infections caused by herpes simplex virus type 1 (HSV-1) can lead to HSV-1 encephalitis-a rare but deadly condition that ...

But, it turns out that quiet isn’t passive at all. In fact, after just three days of intentional silence, the brain begins to physically and functionally rewire itself. A growing body of ...

Vir Biotechnology, Inc. (NASDAQ:VIR) has already been able to initiate its late-stage ECLIPSE program, which is using the combination of monoclonal antibody tobevibart in combination with small ...

Brain scans now show that fasting doesn’t just influence how we eat, it reshapes how we think by changing our brains. The practice appears to strengthen regions of the brain involved in focus ...

Researchers at the UVA School of Medicine found blocking a brain-defense molecule in mice prevented memory loss and other ...

For the brain to dedicate itself to tasks that need attention, or to respond to unexpected stimuli like a fire alarm, it needs to be able to rewire itself by changing how brain cells communicate.

A study of long-distance runners shows the brain’s remarkable ability to adapt—by burning its own fat. A marathon taxes more than just muscles—it pushes the brain to its metabolic limits.

There, a CT scan showed blood clots in Adriana Smith’s brain, and the 30-year-old nurse was soon declared brain-dead, NBC affiliate WXIA-TV reported. Three months later, her mother says Smith is ...

A new report from The Wall Street Journal (Apple News+ link) today dives deeper into another accessibility breakthrough Apple is developing: the ability to control your iPhone with your brain.

Cash runway guidance into mid-2027 remains unchanged, based on the current operating plan. Vir Biotechnology is fully committed to the continued development of tobevibart and elebsiran in chronic ...